Viyash Scientific Ltd - 512529 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Viyash Scientific, through its subsidiary Alivira Animal Health, acquired 100% of Italy-based pet care company BioForLife for ₹188 crore. This move aims to strengthen its European companion animal health presence and capitalize on the growing market.
Jun 08 2026 12:44:21
Viyash Scientific Ltd - 512529 - Announcement under Regulation 30 (LODR)-Acquisition
Viyash Scientific's step-down subsidiary, Alivira Animal Health, has acquired 100% shareholding in BioForLife Italia s.r.l. for EUR 16.975 million. This acquisition will strengthen Viyash's presence in the Italian companion animal segment, adding an established distribution platform and product capabilities.
Jun 08 2026 12:40:55
Viyash Scientific Ltd - 512529 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Viyash Scientific to conduct a postal ballot for appointing two new Non-Executive, Non-Independent Directors and approving a ₹40 crore one-time performance incentive for CEO Mr. Rajaram Narayanan. The e-voting period is from May 30 to June 28, 2026.
May 29 2026 19:12:10
Viyash Scientific Ltd - 512529 - Announcement under Regulation 30 (LODR)-Credit Rating
Viyash Scientific received a credit rating upgrade to [ICRA] AA- (Stable) from ICRA Ratings, effective April 22, 2026. This occurred after India Ratings and Research withdrew its ratings for the company's bank loan facilities at Viyash's request.
May 22 2026 18:19:10
Viyash Scientific Ltd - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Viyash Scientific confirmed the audio recording of its earnings call for the audited Q4 FY26 financial results, held on May 20, 2026, is available online. This provides investors access to management's commentary on the company's performance.
May 20 2026 20:38:49
Viyash Scientific Ltd - 512529 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Viyash Scientific posted robust Q4 FY26 results with revenue growing 19.1% to Rs.920 crore and net profit soaring 306% to Rs.66.4 crore. Full-year FY26 PAT also saw a significant jump of 1324%, reflecting strong operational performance.
May 19 2026 19:00:37
Viyash Scientific Ltd - 512529 - Board Meeting Outcome for Outcome Of Board Meeting
Viyash Scientific Board approved Q4 FY26 cons. revenue of ₹919.96 cr (up 19.11% YoY) and net profit of ₹48.52 cr (up 207.67% YoY). The company did not recommend any dividend for FY26 and adopted new Articles of Association, subject to shareholder approval.
May 19 2026 18:32:00
Viyash Scientific Ltd - 512529 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Viyash Scientific's Board of Directors will convene on May 19, 2026, to consider and approve the financial results for the fourth quarter and full fiscal year ended March 31, 2026. The board will also consider recommending a dividend for the year.
May 12 2026 11:40:33
Read More